Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

30.37

-0.70 (-2.25%)

At close: Jan 30, 2026, 4:00 PM EST

30.34

-0.03 (-0.10%)

After-hours: Jan 30, 2026, 4:20 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Antisense Oligonucleotide	8.78M
Antisense Oligonucleotide Growth	-29.22%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.